Genetic breakthrough for brain cancer in children
An international research team led by the Research Institute of the McGill University Health Centre (RI MUHC) has made a major genetic breakthrough that could change the way pediatric cancers are treated in the future. The researchers identified two genetic mutations responsible for up to 40 per cent of glioblastomas in children – a fatal cancer of the brain that is unresponsive to chemo and radiotherapy treatment. The mutations were found to be involved in DNA regulation, which could explain the resistance to traditional treatments, and may have significant implications on the treatment of other cancers. The study was published this week in the journal Nature.
Below is a talk that was moderated this past summer by corresponding author Nada Jabado, Clinician and Principal Investigator at RI MUHC. The talk focuses on cancer initiation and cancer growth.
Entry filed under: Biotechnology News and Info from Canadian Universities. Tags: cancer research, genomics, McGill University.